May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML?

Leuk Res. 2007 Feb;31(2):269-71. doi: 10.1016/j.leukres.2006.04.003. Epub 2006 Jun 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Chromosomes, Human, Pair 21 / genetics*
  • Chromosomes, Human, Pair 8 / genetics*
  • Core Binding Factor Alpha 2 Subunit / genetics*
  • Humans
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / genetics*
  • Leukemia, Myeloid / therapy
  • Leukocyte Count
  • Oncogene Proteins, Fusion / genetics*
  • Point Mutation*
  • Prognosis
  • Proto-Oncogene Proteins c-kit / genetics*
  • RUNX1 Translocation Partner 1 Protein
  • Recurrence
  • Remission Induction
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Risk Factors
  • Survival Rate
  • Treatment Outcome

Substances

  • AML1-ETO fusion protein, human
  • Core Binding Factor Alpha 2 Subunit
  • Oncogene Proteins, Fusion
  • RUNX1 Translocation Partner 1 Protein
  • Proto-Oncogene Proteins c-kit